Fate Therapeutics Inc
FATE- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001434316
In the last 90 days, Fate Therapeutics Inc insiders filed 0 open-market purchases and 2 sales; 156 institutions reported holding it in 13F filings for Q2 2026, worth $193.2M in total; no superinvestor holds it.
Q3 2023 vs. Q2 2023
How the institutions holding Fate Therapeutics Inc changed between Q2 2023 and Q3 2023.
All holders in Q3 2023All holders in Q2 2023
| Measure | Q2 2023 | Of which not filed for Q3 2023 | Q3 2023 | Change |
|---|---|---|---|---|
| Holders | 188 | 2 | 171 | −15 |
| Shares | 109.1M | 1.11M | 95.5M | −12.5M (−11.6%) |
| Value | $519.6M | $5.27M | $202.9M | −$311.4M (−60.5%) |
2 institutions that held it in Q2 2023 haven't filed for Q3 2023 yet. Not filing isn't selling, so the changes leave them out.
New holders (20)
Institutions that held Fate Therapeutics Inc at the end of Q3 2023 but not at the end of Q2 2023.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| AQR Capital Management LLC | 332,911 | $705.8K | 0.00% |
| PDT Partners, LLC | 138,814 | $294.3K | 0.04% |
| Putnam Investments LLC | 133,250 | $282.5K | 0.00% |
| SG Americas Securities, LLC | 73,642 | $156.0K | 0.00% |
| Verition Fund Management LLC | 52,654 | $111.6K | 0.00% |
| Aigen Investment Management, LP | 42,798 | $90.7K | 0.02% |
| Sciencast Management LP | 31,540 | $66.9K | 0.03% |
| Royce & Associates LP | 30,339 | $64.3K | 0.00% |
| Schonfeld Strategic Advisors LLC | 19,200 | $40.7K | 0.00% |
| Brevan Howard Capital Management LP | 17,337 | $36.8K | 0.01% |
| Herbst Group, LLC | 15,700 | $33.3K | 0.02% |
| JustInvest LLC | 14,354 | $30.4K | 0.00% |
| State of Wyoming | 14,259 | $30.2K | 0.01% |
| Sawtooth Solutions, LLC | 12,012 | $25.5K | 0.00% |
| Bleakley Financial Group, LLC | 12,012 | $25.5K | 0.00% |
| Fox Run Management, L.L.C. | 12,000 | $25.4K | 0.01% |
| National Bank of Canada | 12,000 | $22.9K | 0.00% |
| Victory Capital Management Inc | 10,182 | $21.6K | 0.00% |
| Group One Trading, L.P. | 6,289 | $13.3K | 0.00% |
| Glassman Wealth Services | 53 | $112 | 0.00% |
Sold out (35)
Institutions that held Fate Therapeutics Inc at the end of Q2 2023 and filed for Q3 2023 without it.
Not filed for Q3 2023 yet (2)
Institutions that held Fate Therapeutics Inc at the end of Q2 2023 and haven't filed a 13F for Q3 2023. Not filing isn't selling, so they aren't counted as sold out.
| Institution | Shares, Q2 2023 | Value, Q2 2023 |
|---|---|---|
| Pictet Asset Management SA | 1,090,260 | $5.19M |
| Tiaa, FSB | 17,592 | $83.7K |